Karen Knudsen, Chief Executive Officer at Parker Institute for Cancer Immunotherapy, shared a post on LinkedIn:
“What a week!
There’s nothing more inspiring than seeing the journey from scientific discovery to patient impact, live and in person. Just returned from time with exceptional CEO Pascal Soriot and my fellow AstraZeneca Board members at our Maryland sites – complete with AZ scientific and business leaders, a town hall with the Maryland team, and a tour of the Frederick Manufacturing Center. We kicked it all off with our announcement re: a new U.S. investments, including a Virginia site made that will expand capacity and save more lives.
Kudos to the global AZ team, who are science-led, patient-focused, and dedicated to improving lives.”
More posts featuring Karen Knudsen.